Anti-HCV Prevalence among Diabetic and Non-Diabetic Egyptian Children

Current Diabetes Reviews

Volumn 6, Issue 6, 2010, Pages 388-392

  El Karaksy, H ^a   Anwar, G H ^a   El Raziky, M S ^a   El Hawary, M ^b   Hashem, M ^d   El Sayed, R ^a   El Shabrawi, M ^a   Mohsen, N ^a   Fouad, H ^c   Esmat, G ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b FAYOUM UNIVERSITY   (Egypt)

^c National Hepatology and Tropical Medicine Research Institute   (Egypt)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Children; HCV; Infection control; Standard precautions; Type 1 diabetes mellitus

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; DIABETES MELLITUS; DISEASE TRANSMISSION; ECHOGRAPHY; EGYPT; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; MALE; PRESCHOOL CHILD; RISK FACTOR; VIROLOGY;

ADOLESCENT; ALANINE TRANSAMINASE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; EGYPT; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INFANT; LIVER; MALE; RISK FACTORS; RNA, VIRAL;

MLCS; MLOWN;

EID: 79952276641     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339910793499137     Document Type: Article

References (24)

1. Bhattacharya S, Badrinath S, Hamide A, Sujatha S. Co-infection with hepatitis C virus and human immunodeficiency virus among patients with sexually transmitted diseases in Pondicherry, South India. Indian J Pathol Microbiol 2003; 46: 495-7.
2. Tovo P, Newell M. Hepatitis C in children. Curr Opin Infect Dis 1999; 12: 245-50.
3. El-Raziky MS, El-Hawary M, El-Koofy N, et al. Hepatitis C virus infection in Egyptian children: single centre experience. J Viral Hepatol 2004; 11: 471-6.
4. El-Hawary MA, El-Raziky MS, Esmat G, et al. Assessment of hepatic fibrosis in pediatric cases with hepatitis C virus in Egypt. World J Gastroenterol 2007; 13: 2846-51.
5. Wilber JC. Hepatitis C virus. In: Murray PR. Manual of Clinical Microbiology, 6th ed. ASM Press, Washington DC 1995: 1050-5.
6. El-Raziky MS, El-Hawary M, Esmat G, et al. Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol 2007; 13: 1828-32.
7. Baig NA, Herrine SK, Rubin R. Liver disease and diabetes melli-tus. Clin Lab Med 2001; 21: 193-207.
8. Rudoni S, Petit JM, Bour JB, et al. HCV infection and diabetes mellitus: influence of the use of finger stick devices on nosocomial transmission. Diabet Metab 1999; 25: 502-5.
9. Cadranel JF, Di Martino V, Lambrey G, et al. Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: re-sults of a cross-sectional study. Eur J Gastroenterol Hepatol 2008; 20: 829-36.
10. El-Nawawy AA, El-Azzouni OF, Soliman AT, Amer AE, Demian RS, El-Sayed HM. Prevalence of hepatitis-C antibody seropositiv-ity in healthy Egyptian children and four high risk groups. J Trop Pediatr 1995; 41: 341-3.
11. Kandil ME, Rasheed MA, Saad NE. Hepatitis C and B viruses among some high risk groups of Egyptian children. J Med Sci 2007; 7: 1259-67.
12. Cerutti F, Palomba E, Sacchetti C, Gay V, Versace A, Tovo PA. Anti-HCV antibodies in a population of insulin-dependent Diabetic children and adolescents. Diabetes Care 1999; 22: 1587-8.
13. Desenclos JC, Bourdiol-Razès M, Rolin B, et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: Possible transmission by spring-loaded finger-stick devices for self monitoring of capil-lary blood glucose. Infect Control Hosp Epidemiol 2001; 22: 701-7.
14. Noor A, Gulfraz M and Aslam B. Assessment of HBsAg and Anti-HCV in some area of Pakistan. J Biologic Sci 2002; 2: 202-3.
15. Khan HI. A study of seroprevalence of hepatitis B and C in moth-ers and children in Lahore. Pak Ped J 1996; 20: 163-6.
16. Habib M, Mohamed MK, Abdel-Aziz F, et al. Hepatitis C infection in a community in the Nile Delta: Risk factors for seropositivity. Hepatology 2001; 33: 248-53.
17. Frank C, Mohamed MK, Strickland GT, et al. The role of par-enteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 9207: 887-91.
18. Abdel-Aziz F, Habib M, Mohamed MK, et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population de-scription and HCV prevalence. Hepatology 2000; 32: 111-5.
19. Medhat A, Shehata M, Magder LS, et al. Hepatitis C in a community in Upper Egypt: Risk factors for infection. Am J Trop Med Hyg 2002; 66: 633-8.
20. Centers for Disease Control and Prevention (CDC). Multi-dose vial linked to nosocomial HCV outbreak. Hosp Infect Control 2000; 20: 68-69.
21. Hyder SN, Hussain W, Aslam M, Maqbool S. Seroprevalence of anti-HCV in asymptomatic children. Pak Ped J 2001; 25: 89-93.
22. Balter S, Layton M, Bornschlegel K, et al. Transmission of hepatitis B and C viruses in outpatient settings-New York, Oklahoma and Nebraska, 2000-2002. MMWR 2003; 52: 901-6.
23. Comparcola D, Nobili V, Sartorelli MR, Marcellini M, Cainelli F and Vento S. Childhood hepatitis C virus infection. J Gastroenterol Hepatol 2005; 20: 1948-52.
24. Takaike H, Uchigata Y, Iwasaki N, Iwamoto Y. Transient elevation of liver transaminase after starting insulin therapy for diabetic keto-sis or ketoacidosis in newly diagnosed type 1 diabetes mellitus. Diabetes Res Clin Pract 2004; 64: 27-32.